Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Bruker (BRKR) over the last 16 years, with Q3 2025 value amounting to $258.4 million.

  • Bruker's Cash from Financing Activities rose 967037.04% to $258.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $227.7 million, marking a year-over-year decrease of 8170.94%. This contributed to the annual value of $1.2 billion for FY2024, which is 73588.42% up from last year.
  • Latest data reveals that Bruker reported Cash from Financing Activities of $258.4 million as of Q3 2025, which was up 967037.04% from $95.5 million recorded in Q2 2025.
  • In the past 5 years, Bruker's Cash from Financing Activities ranged from a high of $1.2 billion in Q2 2024 and a low of -$217.4 million during Q1 2022
  • For the 5-year period, Bruker's Cash from Financing Activities averaged around $65.4 million, with its median value being -$36.1 million (2022).
  • As far as peak fluctuations go, Bruker's Cash from Financing Activities tumbled by 305384.62% in 2022, and later soared by 1132135.92% in 2024.
  • Bruker's Cash from Financing Activities (Quarter) stood at $404.3 million in 2021, then tumbled by 108.93% to -$36.1 million in 2022, then crashed by 65.93% to -$59.9 million in 2023, then dropped by 25.21% to -$75.0 million in 2024, then surged by 444.53% to $258.4 million in 2025.
  • Its last three reported values are $258.4 million in Q3 2025, $95.5 million for Q2 2025, and -$51.2 million during Q1 2025.